Schwartz SM, et al. – Researchers investigated whether CHA₂DS₂-VASc and HAS-BLED scores offer different risk estimations for stroke and bleeding, respectively, among white vs non-white atrial fibrillation (AF) patients in this retrospective cohort study. Researchers examined AF patients not prescribed anticoagulation to determine the links between stroke and CHA₂DS₂-VASc score, and assessed the link between incident bleeding and HAS-BLED score in anticoagulated patients. Findings revealed that non-white patients less frequently received oral anticoagulation prescriptions. However, CHA₂DS₂-VASc and HAS-BLED demonstrated similar discriminative ability between whites and non-white individuals.